Brenton K. Ahrens - Jun 25, 2022 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Brenton K. Ahrens
Stock symbol
ITRM
Transactions as of
Jun 25, 2022
Transactions value $
$0
Form type
4
Date filed
6/28/2022, 09:00 PM
Previous filing
Jun 17, 2022
Next filing
Sep 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Stock Option (Right to Buy) Award $0 +113K $0.00 113K Jun 25, 2022 Ordinary Shares 113K $0.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated 2018 Equity Incentive Plan, as amended, the shares subject to this option shall vest in full on April 1, 2023